back to US directory
us clinical guidance

Hand, hip and knee osteoarthritis

ACR/Arthritis Foundation鈥揵ased nonoperative management for hand, hip and knee osteoarthritis; arthroplasty timing remains an evidence gap.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with symptomatic osteoarthritis of the hand, hip or knee. The ACR/Arthritis Foundation guideline addresses management rather than every diagnostic differential. Acute hot joint, fracture, inflammatory arthritis, infection, osteonecrosis and spine or shoulder osteoarthritis require separate assessment.
sources for this section:ACR/AF OA

The Bottom Line

  • Make a clinical and functional assessment from pain pattern, stiffness, activity limitation, examination and the probability of an alternative diagnosis; imaging severity and pain can be discordant.
  • Recommend exercise for knee, hip and hand osteoarthritis and weight loss for patients with knee or hip disease who are overweight or obese, using a sustainable program matched to function and preference.
  • Use self-management education, appropriate bracing or assistive devices and physical or occupational therapy as active treatments rather than waiting for radiographic progression.
  • Prefer topical NSAID before oral exposure for knee disease when practical; individualize oral NSAID, acetaminophen, duloxetine or intra-articular glucocorticoid from joint, comorbidity and prior response.
  • Do not infer arthroplasty referral criteria, prerequisites or timing from this nonoperative ACR/AF source; those decisions require a separate exact current US surgical authority.
sources for this section:ACR/AF OA

Practical clinical workflow

1
Clarify affected joints, morning stiffness duration, swelling, trauma, mechanical symptoms, sleep, mood, work, activity goals and previous treatment; examine gait, range, alignment, strength and inflammatory signs.
2
Obtain plain radiographs when diagnosis is uncertain, symptoms are atypical or intervention planning needs them; avoid routine MRI for a typical clinical presentation without a management-changing question.
3
Build a core plan of education, graded strengthening and aerobic activity, weight support when relevant and a joint-specific aid or orthosis; agree functional outcomes for review.
4
Add medication after gastrointestinal, renal, cardiovascular, anticoagulant and fall-risk review; use the lowest effective systemic exposure and monitor benefit rather than continuing by default.
5
Reassess function and goals and obtain appropriate evaluation when the diagnosis is uncertain or inflammatory features emerge; use a separately sourced surgical pathway if arthroplasty is being considered.
sources for this section:ACR/AF OA

Safety boundaries and escalation

  • An acutely hot, swollen joint with fever or systemic illness requires urgent aspiration and septic-arthritis evaluation rather than an osteoarthritis label.
  • Sudden inability to bear weight after trauma or with osteoporosis risk needs fracture assessment; progressive neurologic signs are not explained by peripheral osteoarthritis.
  • Oral NSAIDs can cause gastrointestinal bleeding, kidney injury, fluid retention and cardiovascular harm; review interacting drugs and monitor high-risk patients.
  • Do not use stem-cell, platelet-rich-plasma or other marketed injections as though efficacy and product quality were established by the ACR/AF guideline.
sources for this section:ACR/AF OA

Localization

Use ACR/AF recommendations within their nonoperative management scope, alongside current FDA labeling and US therapy access. This source does not establish a US orthopedic referral threshold.
sources for this section:ACR/AF OA

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Rheumatology and Arthritis Foundation2019 Guideline for the Management of Osteoarthritis of the Hand, Hip, and KneeDOI 10.1002/acr.24131 路 published 2020-02-01 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.